Skip to Main Content

AbbVie’s $63 Billion Acquisition of Allergan Wins FTC Nod with Divestitures

  • May 08, 2020

The Federal Trade Commission (FTC) cleared May 5 drug maker AbbVie Inc.’s acquisition of rival Allergan plc after the companies agreed to divest three drug products.

 

Keep reading this article by creating an account or logging in.